Exploring the relationship between health policy, public health and the law regarding the controversial use of cannabis, this study assesses the impact of illegality in drug use and compares it with the policies of the U.S., Europe and Australia as well as other developed societies. Current debates about "safe use" and "harm minimization" approaches are evaluated, as well as the experiences of differing prevention, treatment and education policies. Written by two leading drug advisors, the analysis contributes to an important field of research.
This report is part of the RAND Corporation Commercial book series. Periodically, RAND Corporation researchers publish with commercial presses. These books are not available from RAND but can be requested directly from the publisher, except in cases where the rights have reverted to RAND and we have republished a new edition.
Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit www.rand.org/about/principles.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.